Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastoma

By Michael W. Ronellenfitsch, Pia S. Zeiner, Michel Mittelbronn, Hans Urban, Torsten Pietsch, Dirk Reuter, Christian Senft, Joachim P. Steinbach, Manfred Westphal and Patrick N. Harter On Aug 22, 2018

Glioblastoma (GB) is the most frequent primary brain tumor in adults with a dismal prognosis despite aggressive treatment including surgical resection, radiotherapy and chemotherapy with the alkylating agent t…

neuropathology

admin 26477 posts 0 comments

Endovascular Treatment of Intracranial Atherosclerotic Stenosis: Current Debates and Future Prospects

Insights into microbiome research 1: How to choose appropriate controls for a microbiome study in MS?